Spirometry is a test conducted by medical professionals to evaluate the status of lungs in order to diagnose the disorders related to the functioning of lungs. Spirometers are the medical devices that are utilized to conduct spirometry. The Spirometry Market is anticipated to reach USD 849.53 million by 2030 at 10.90% CAGR during the forecast period 2022-2030.
Market Drivers and Restraints:
Rise in prevalence of lung disorders due to increasing pollution, changing lifestyle, tobacco smoking addiction and others are inducing high demand for improved spirometry tests in the global market, which in turn is propelling the growth of the global spirometry market. Introduction of advanced medical devices that are compact and easy-to-use and increased healthcare expenditure are some other important factors that are fueling the growth of the global spirometry market. However, lack of awareness and low penetration of technologically advanced healthcare solutions are some of the major factors that are likely to restrain the growth of the global spirometry market during the assessment period.
Request Free Sample Copy at:
The global spirometry market has been segmented on the basis of product, technology, application, and end-user. Based on product, the spirometry market has been segmented into table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. Based on technology, the spirometry market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry. The flow measurement spirometry technology segment is sub-segmented into pneumotachograph system and mass flow meter. Based on application, the spirometry market has been segmented into diagnostic and treatment monitoring. The diagnostic segment has been sub-segmented into COPD, asthma, and interstitial pulmonary fibrosis. Based on end-users, the spirometry market has been segmented into research academic institutes, diagnostic centers, hospitals clinics, and home care.
Geographically, the global human growth hormone market has been segmented into the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas accounted for the major share of 39.74% in the global spirometry market owing to the easy adoption of technically advanced medical devices, high prevalence of pulmonary disorders due to pollution and changing lifestyle and high healthcare expenditure by the population in this region. The Europe region is forecasted to expand at a significant growth rate in the global spirometry market during the assessment period owing to the high demand for advanced spirometers in the well-developed healthcare sector and proliferation of asthma cases in this region. The spirometry market in the Asia Pacific region is anticipated to expand at a notable growth rate in the global market owing to the increasing awareness regarding lung disorders and their adverse effects on health, increasing adoption of advanced healthcare solutions and high prevalence of lung disorders in this region. Improvement in healthcare infrastructure and enhanced healthcare budget are driving the spirometry market in the Middle East and Africa region.
In June 2018, Henry Schein Medical, a U.S.-based medical business of Henry Schein, Inc., has announced the launch of its new all-in-one solution for lung function testing, Henry Schein EasyOne Air spirometer. this spirometer can potentially improve recognition and diagnosis of Chronic Obstructive Pulmonary Disease (COPD).
In April 2018, NuvoAir, a Sweden-based respiratory monitor maker which was formerly known as Pond Healthcare Innovation, has launched the newest version of its home-use spirometer, a device that is portable and can be connected to smartphones and tablets via Bluetooth. This device is named as the air next, an upgrade to the previously launched device, the Air Smart Spirometer.
The leading players profiled by MRFR that are operating in the global spirometry market are Carefusion Corporation (the U.S.), NDD Medical Technologies, Inc. (the U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (the U.S.), Vitalograph (the U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (the U.S.), Midmark Corporation (the U.S.), Smiths Medical Inc. (the U.S.), and Koninklijke Philips N.V. (The Netherlands).
Browse Detailed TOC with COVID-19 Impact Analysis at:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071